Back to top

Ahead of Wall Street

Monday, February 5, 2018

A series of curious events occurred last Friday morning, which continued — Rube Goldberg-like — throughout the day and, it may be argued, even into this morning’s pre-market trading action. Friday’s Dow closed down 673 points, or -2.57%, while the Nasdaq and S&P 500 hived off roughly 2% each. The Dow looks to open down another triple digits, although we’ve seen some early buying back from how low we started this morning.

The first thing to have happened was the non-farm payroll report Friday morning, which posted another very strong month for employment gains (+200K). Average Hourly Earnings also gained another third of a percent, meaning wage growth is showing signs of adding to overall inflation in the U.S. And talk of a fourth interest rate hike in the next 12 months from the Fed when incoming Chairman Jay Powell takes over added to the already +50% likelihood of three rate hikes, beginning next month.

From there we saw the 10-year bond yield spike up past 2.8%. As Zacks Strategist Tracey Ryniec remarked in real time on Friday, “A strong economy and inflation means no more free money.” Zacks’ Dave Bartosiak reacted, “Perhaps this is the bond market telling the US, ‘We’re a little concerned with that debt situation you’ve got now that you’ve cut those tax rates.’” And Senior Strategist Kevin Cook looked at the VIX and said, “Volume still looks tame, no huge fear. Spot VIX is acting like 1% moves could be normal again. Futures are hardly panicked.”

Cook also points out that last week was the worst week… of one of the best two-year rallies we’ve ever seen. Markets are up 65%, so this correction is a mere pittance by comparison. Especially considering — if you can remember back to January 2016, not all that long ago — we saw a sell-off of 6.2%. Right now, even with Monday futures again in sell-off mode, we’re only looking at around -5%. Not really in the same ballpark, at least not yet.

Earnings Estimates Going Up

If you’re still concerned about markets swooning to start this new week, a good tonic for you might be Zacks Director of Research Sheraz Mian’s latest Earnings Preview, where he points out not only is Q4 earnings season the best we’ve seen in years, but future earnings guidance is shooting up for future quarters. So while we do see some near-term pressure on valuations — which outgoing Fed Chair Janet Yellen did mention was somewhat of a concern going forward — the name of the game is still earnings, and those are only pointing north.

Q4 Earnings Roundup

Last week saw a host of marquee names posting quarterly earnings reports, with mostly good results. In fact, the only bottom-line misses we saw stemmed from tax-related write-downs, which are essentially near-term in nature, and not a result of missed expectations (Apple’s [(AAPL - Free Report) ] lower-than-anticipated iPhone X sales notwithstanding). This week, we see just as many reports hitting the tape, even if they are not quite the same household names as last week.

Foodservice giant Sysco (SYY - Free Report) beat estimates on both its top- and bottom-lines this morning, with 78 cents per share on $14.41 billion surpassing the 65 cents per share and $14.19 billion in revenues expected. Earnings results for the Zacks Rank #2 (Buy) company rose 34.5% year over year. For more on SYY’s earnings, click here.

British pharma major Bristol Myers (BMY - Free Report) also topped expectations, beating on the bottom line by a penny to 68 cents per share, and quarterly sales of $5.45 billion outpaced the $5.31 billion in the Zacks consensus estimate. Guidance was ratcheted up a bit, but still within the Zacks consensus. For more on BMY’s earnings, click here.

And Arconic , the engineered products segment that formerly belonged to aluminum giant Alcoa (AA - Free Report) , easily outperformed both sales and earnings estimates. The company saw 31 cents per share on $3.27 billion in revenues, ahead of the 24 cents per share and $3.07 billion we had been expecting. Guidance on the top-line rose past the Zacks consensus, while full-year earnings remain in-range. For more on ARNC’s earnings, click here.

Mark Vickery
Senior Editor

Questions or comments about this article and/or its author? Click here>>

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.

Click here for Zacks' private trades >>

Stocks On The Move

Company Symbol Price $Change %Change
ADMA Biologics Inc ADMA 8.81 1.88 27.13
Groupon, Inc. GRPN 12.97 2.47 23.52
CRH PLC CRH 83.77 3.45 4.30
Veracyte, Inc. VCYT 21.37 0.74 3.59
Gold Fields Limited GFI 16.94 0.48 2.92

Zacks Equity Research15/16

We cover more than 1,000 of the most widely followed stocks in our Equity Research Reports. Each report features independent research from our analysts and provides in-depth analysis on a company, its fundamentals and its growth prospects. Quickly access reports for New Upgrades and New Downgrades.

You can also find a report on the ticker of your choice, or access all of the stock reports covered by Zacks analysts.

View All Zacks Equity Research Reports

Zacks Analyst Reports

View All

New Upgrades: SIMO, ALL, UBS, CBT, HWM, WRK, TSN, VMI, TJX, UTHR

New Downgrades: TECK, ROK, KMT, BABA, AGCO, SWKS, CDW, SFIX, FLEX, FIVE

Find a Report

Get timely analysis that provides the reason behind the Zacks Rank for more than 4,400 stocks

Earnings and Economic News

Key Earnings Reports For May 11, 2024

No Earnings and Economic News found for May 11, 2024